Ewing's Sarcoma Family of Tumors: Current Management
Mark L. Bernstein(University of Louisville), Herbert Juergensg(University Hospital Münster)
Cited by 518
Related Papers
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
|The Lancet Oncology|2016|537
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
|Journal of Clinical Oncology|2015|419
Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.
|PubMed|2003|198
Conduct of phase I trials in children with cancer.
|Journal of Clinical Oncology|1998|93